Tissue Regenix signs European distribution agreement with Arthrex

Writer, Stock Market Wire
Tuesday, November 13, 2018 - 09:19

Regenerative medical devices company Tissue Regenix Group said it had entered into an agreement allowing Arthrex to distribute its BioRinse bone portfolio throughout Europe, with the initial focus on the UK.

The agreement built on an existing US relationship signed in March 2018.

'Since signing the US distribution agreement in March we have continued to build a strong alliance, identifying areas where we can work together and leverage the expertise of both companies,' chief executive Steve Couldwell said.

'This European agreement allows us to exploit not only our ability to import our BioRinse bone portfolio into the UK facility, but also Arthrex' expansive distribution network, another significant milestone towards our vision of building a leading force in regenerative medicine.'

At 9:19am: (LON:TRX) Tissue Regenix Group PLC share price was +0.15p at 7.4p


Related content

Tissue Regenix signs 10-year lease on facility in US to ramp up processing capacity

Medical devices group Tissue Regenix signed a 10-year lease agreement on a facility to expand processing capacity at its manufacturing base in San Antonio, Texas....

Thu, 15/08/2019 - 08:46


CEO Steve Couldwell resigns from Tissue Regenix due to illness

Regenerative medical devices company Tissue Regenix Group said that CEO Steve Couldwell had resigned his position 'with immediate effect' due to a recurrence of illness....

Thu, 01/08/2019 - 09:45


Tissue Regenix secures $20m in loan facilities

Regenerative medical devices company Tissue Regenix Group said some of its subsidiaries had agreed with MidCap Financial Trust to access a revolving credit facility and...

Tue, 04/06/2019 - 07:31


Tissue Regenix CEO to return to full-time duties after medical treatment

Regenerative medical devices company Tissue Regenix Group said chief executive Steve Couldwell would return to full time duties during June.

Couldwell had taken a leave...

Tue, 21/05/2019 - 08:25


Tissue Regenix secures additional coverage in the US for DermaPure

Tissue Regenix secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a decellularized allograft dermis.

The company said the...

Thu, 04/04/2019 - 07:48